These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 14517320)

  • 1. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
    Volonte D; Peoples AJ; Galbiati F
    Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
    Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
    Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
    Smythe GM; Eby JC; Disatnik MH; Rando TA
    J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolae and caveolin-3 in muscular dystrophy.
    Galbiati F; Razani B; Lisanti MP
    Trends Mol Med; 2001 Oct; 7(10):435-41. PubMed ID: 11597517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.
    Galbiati F; Volonte D; Minetti C; Chu JB; Lisanti MP
    J Biol Chem; 1999 Sep; 274(36):25632-41. PubMed ID: 10464299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin and NOS in the Development of Muscular Dystrophy.
    Nakashima M; Suga N; Yoshikawa S; Matsuda S
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
    Galbiati F; Volonte D; Chu JB; Li M; Fine SW; Fu M; Bermudez J; Pedemonte M; Weidenheim KM; Pestell RG; Minetti C; Lisanti MP
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9689-94. PubMed ID: 10931944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
    Galbiati F; Engelman JA; Volonte D; Zhang XL; Minetti C; Li M; Hou H; Kneitz B; Edelmann W; Lisanti MP
    J Biol Chem; 2001 Jun; 276(24):21425-33. PubMed ID: 11259414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
    Minetti C; Bado M; Broda P; Sotgia F; Bruno C; Galbiati F; Volonte D; Lucania G; Pavan A; Bonilla E; Lisanti MP; Cordone G
    Am J Pathol; 2002 Jan; 160(1):265-70. PubMed ID: 11786420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.
    Merrick D; Stadler LK; Larner D; Smith J
    Dis Model Mech; 2009; 2(7-8):374-88. PubMed ID: 19535499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy.
    Herrmann R; Straub V; Blank M; Kutzick C; Franke N; Jacob EN; Lenard HG; Kröger S; Voit T
    Hum Mol Genet; 2000 Sep; 9(15):2335-40. PubMed ID: 11001938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.
    Galbiati F; Volonte D; Minetti C; Bregman DB; Lisanti MP
    J Biol Chem; 2000 Dec; 275(48):37702-11. PubMed ID: 10973975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-3 deficiency causes muscle degeneration in mice.
    Hagiwara Y; Sasaoka T; Araishi K; Imamura M; Yorifuji H; Nonaka I; Ozawa E; Kikuchi T
    Hum Mol Genet; 2000 Dec; 9(20):3047-54. PubMed ID: 11115849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy.
    Repetto S; Bado M; Broda P; Lucania G; Masetti E; Sotgia F; Carbone I; Pavan A; Bonilla E; Cordone G; Lisanti MP; Minetti C
    Biochem Biophys Res Commun; 1999 Aug; 261(3):547-50. PubMed ID: 10441463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy.
    Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2867-76. PubMed ID: 24072696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of caveolin-3 induced by the dystrophy-associated P104L mutation impairs L-type calcium channel function in mouse skeletal muscle cells.
    Couchoux H; Allard B; Legrand C; Jacquemond V; Berthier C
    J Physiol; 2007 May; 580(Pt.3):745-54. PubMed ID: 17317753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning.
    Nixon SJ; Wegner J; Ferguson C; Méry PF; Hancock JF; Currie PD; Key B; Westerfield M; Parton RG
    Hum Mol Genet; 2005 Jul; 14(13):1727-43. PubMed ID: 15888488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease.
    Hnasko R; Lisanti MP
    Mol Interv; 2003 Dec; 3(8):445-64. PubMed ID: 14993453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
    Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
    Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filopodia powered by class x myosin promote fusion of mammalian myoblasts.
    Hammers DW; Hart CC; Matheny MK; Heimsath EG; Lee YI; Hammer JA; Cheney RE; Sweeney HL
    Elife; 2021 Sep; 10():. PubMed ID: 34519272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.